Azenta, Inc. (AZTA)
Company Description
Azenta, Inc. provides life science sample exploration and management solutions for the life sciences market in North America, Europe, China, the Asia Pacific, and internationally.
The company operates through two reportable segments, Life Sciences Products and Life Sciences Services.
The Life Sciences Products segment offers automated cold sample management systems for compound and biological sample storage; equipment for sample preparation and handling; consumables; and instruments that help customers in managing samples throughout their research discovery and development workflows.
The Life Sciences Services segment provides comprehensive sample management programs, integrated cold chain solutions, informatics, and sample-based laboratory services to advance scientific research and support drug development.
This segment's services include sample storage, genomic sequencing, gene synthesis, laboratory processing, laboratory analysis, biospecimen procurement, and other support services.
It serves a range of life science customers, including pharmaceutical companies, biotechnology companies, biorepositories, and research institutes.
The company was formerly known as Brooks Automation, Inc. and changed its name to Azenta, Inc. in December 2021.
Azenta, Inc. was founded in 1978 and is headquartered in Chelmsford, Massachusetts.
| Country | United States |
| Founded | 1978 |
| IPO Date | Feb 1, 1995 |
| Industry | Medical Instruments & Supplies |
| Sector | Healthcare |
| Employees | 3,200 |
| CEO | Stephen Schwartz |
Contact Details
Address:
200 Summit Drive, 6th Floor Burlington, Massachusetts 01803 United States | |
| Phone | (978) 262-2400 |
| Website | azenta.com |
Stock Details
| Ticker Symbol | AZTA |
| Exchange | NASDAQ |
| Fiscal Year | October - September |
| Reporting Currency | USD |
| CIK Code | 0000933974 |
| CUSIP Number | 114340102 |
| ISIN Number | US1143401024 |
| Employer ID | 04-3040660 |
| SIC Code | 3559 |
Key Executives
| Name | Position |
|---|---|
| Dr. Stephen S. Schwartz | Chief Executive Officer, President and Director |
| Lindon G. Robertson | Executive Vice President and Chief Financial Officer |
| Robin Vacha | Senior Vice President of Global Operations |
| Michael Paulo | Vice President and Chief Information and Digital Officer |
| Sara Silverman | Head of Investor Relations |
| Jason W. Joseph | Senior Vice President, General Counsel and Corporate Secretary |
| John E. O'Brien | Senior Vice President of Corporate Development |
| Claribel Purcell | Senior Vice President of Global Sales |
| Kimberly Crowley | Senior Vice President and Chief Human Resources Officer |
| J. Robert Woodward | Senior Vice President of Global Quality and Regulatory |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jan 10, 2023 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Jan 6, 2023 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Dec 21, 2022 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Dec 21, 2022 | DEF 14A | Other definitive proxy statements |
| Dec 15, 2022 | 8-K/A | [Amend] Current report |
| Nov 25, 2022 | 10-K | Annual Report |
| Nov 23, 2022 | 8-K | Current Report |
| Nov 14, 2022 | 8-K | Current Report |
| Oct 17, 2022 | 8-K | Current Report |
| Oct 7, 2022 | 8-K | Current Report |